LEXINGTON, Mass., Sep 07, 2011 (BUSINESS WIRE) — AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate at the Baird 2011 Healthcare Conference on September 8 at 11:00 am ET in New York City. Company management will provide an overview of the company followed by a question and answer period with investors.
A live webcast of the presentation will be accessible through the Investors section of the Company’s website at https://www.amagpharma.com. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website until September 16, 2011.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit https://www.amagpharma.com.
SOURCE: AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc.
Carol Miceli, 617-498-3361
